-
Advising Biohaven on entering into a collaboration agreement with Pfizer, and on the later $11.6 billion sale of Biohaven Pharmaceutical Ireland DAC to Pfizer.
-
Advising an international energy and chemicals group on the implications for its REACH registration as part of a tax restructuring process.
-
Acting for Biosynth International Inc., a KKR portfolio company, on its circa $30 million purchase of Benen Trading Limited and Fitzgerald Industries from Trinity Biotech.
-
Advising a NYSE listed clinical-stage biopharmaceutical company on its global IP restructuring and commercialisation project.
-
Advising a global medtech company on restructuring of corporate structure and intragroup arrangements to achieve additional efficiencies and minimise tax leakage.
-
Advising a global medtech company on the implementation of their transfer pricing policies including drafting of an intragroup framework and operating agreements.
-
Advising a number of multinational life sciences companies on the availability of research and development tax credits and the Irish Patent Box regime for intellectual property development and exploitation activities.
-
Advising Comar Holdings LLC, a custom medical devices supplier, on its acquisition of the entire issued share capital of the pharmaceutical injection moulded products supplier Automatic Plastics Ltd.
